Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Doi

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|March 20, 2015
Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - Nobuhiro Nishii, Motoki Kubo, Yoji Okamoto, et al.
The Journal of Biological Chemistry|February 1, 2002
Recombinant human laminin-10 (alpha5beta1gamma1). Production, purification, and migration-promoting activity on vascular endothelial cellsMasayuki Doi, Jill Thyboll, Jarkko Kortesmaa, et al.
JACC. Asia|January 31, 2025
Evaluating Pericoronary Adipose Tissue Attenuation to Predict Cardiovascular Events: A Multicenter Study in East AsiansTakahiro Nishihara, Toru Miyoshi, Kentaro Ejiri, et al.
The American Journal of the Medical Sciences|March 18, 2010
Combination therapy of calcium channel blocker and angiotensin II receptor blocker reduces augmentation index in hypertensive patientsMasayuki Doi, Toru Miyoshi, Satoshi Hirohata, et al.
Journal of Cardiovascular Development and Disease|May 27, 2022
Effect of Early Initiation of Evolocumab on Lipoprotein(a) in Patients with Acute Myocardial Infarction: Sub-Analysis of a Randomized Controlled TrialTomoaki Okada, Toru Miyoshi, Masayuki Doi, et al.
International Journal of Cardiology. Heart & Vasculature|January 4, 2019
Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trialKentaro Ejiri, Toru Miyoshi, Kunihisa Kohno, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 6, 2013
Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fractionKazumasa Nosaka, Kazufumi Nakamura, Kengo Kusano, et al.
Nutrients|January 22, 2021
Secular Decreasing Trend in Plasma Eicosapentaenoic and Docosahexaenoic Acids among Patients with Acute Coronary Syndrome from 2011 to 2019: A Single Center Descriptive StudyTomoaki Okada, Toru Miyoshi, Masayuki Doi, et al.
Acta Medica Okayama|March 2, 2021
Possible Protective Effect of Remote Ischemic Preconditioning on Acute Kidney Injury Following Elective Percutaneous Coronary Intervention: Secondary Analysis of a Multicenter, Randomized StudyHiroaki Otsuka, Toru Miyoshi, Kentaro Ejiri, et al.
Heart and Vessels|November 11, 2010
Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patientsToru Miyoshi, Masayuki Doi, Satoshi Hirohata, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Circulation Journal : Official Journal of the Japanese Circulation Society|March 20, 2015
Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - Nobuhiro Nishii, Motoki Kubo, Yoji Okamoto, et al.
The Journal of Biological Chemistry|February 1, 2002
Recombinant human laminin-10 (alpha5beta1gamma1). Production, purification, and migration-promoting activity on vascular endothelial cellsMasayuki Doi, Jill Thyboll, Jarkko Kortesmaa, et al.
JACC. Asia|January 31, 2025
Evaluating Pericoronary Adipose Tissue Attenuation to Predict Cardiovascular Events: A Multicenter Study in East AsiansTakahiro Nishihara, Toru Miyoshi, Kentaro Ejiri, et al.
The American Journal of the Medical Sciences|March 18, 2010
Combination therapy of calcium channel blocker and angiotensin II receptor blocker reduces augmentation index in hypertensive patientsMasayuki Doi, Toru Miyoshi, Satoshi Hirohata, et al.
Journal of Cardiovascular Development and Disease|May 27, 2022
Effect of Early Initiation of Evolocumab on Lipoprotein(a) in Patients with Acute Myocardial Infarction: Sub-Analysis of a Randomized Controlled TrialTomoaki Okada, Toru Miyoshi, Masayuki Doi, et al.
International Journal of Cardiology. Heart & Vasculature|January 4, 2019
Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trialKentaro Ejiri, Toru Miyoshi, Kunihisa Kohno, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 6, 2013
Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fractionKazumasa Nosaka, Kazufumi Nakamura, Kengo Kusano, et al.
Nutrients|January 22, 2021
Secular Decreasing Trend in Plasma Eicosapentaenoic and Docosahexaenoic Acids among Patients with Acute Coronary Syndrome from 2011 to 2019: A Single Center Descriptive StudyTomoaki Okada, Toru Miyoshi, Masayuki Doi, et al.
Acta Medica Okayama|March 2, 2021
Possible Protective Effect of Remote Ischemic Preconditioning on Acute Kidney Injury Following Elective Percutaneous Coronary Intervention: Secondary Analysis of a Multicenter, Randomized StudyHiroaki Otsuka, Toru Miyoshi, Kentaro Ejiri, et al.
Heart and Vessels|November 11, 2010
Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patientsToru Miyoshi, Masayuki Doi, Satoshi Hirohata, et al.
Pageof 6